Method of treatment with modified arginine deiminase
US7323167B2 · kind B2 · utility
10Cited by
9References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 15, 2004 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Feb 22, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to arginine deiminase modified with polyethylene glycol, to methods of treating cancer, and to methods of treating and/or inhibiting metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.